Company Filing History:
9 out of 9 
9 out of 1,271 
Years Active: 2020-2025
Title: The Innovative Contributions of Hawazin Faruki
Introduction
Hawazin Faruki is a prominent inventor based in Durham, NC (US), known for his significant contributions to the field of cancer research. With a total of 9 patents to his name, Faruki has focused on developing methods and compositions that enhance the understanding and treatment of various cancer subtypes.
Latest Patents
Among his latest patents, Faruki has developed methods for subtyping bladder cancer. These methods provide a way to determine a subtype of Muscle Invasive Bladder Cancer (MIBC) in individuals by detecting the expression level of specific classifier biomarkers. Additionally, these innovations include methods for assessing the response of individuals with MIBC subtypes to therapies such as immunotherapy. Another notable patent involves methods for subtyping lung adenocarcinoma. This work similarly focuses on detecting the expression levels of classifier biomarkers to determine the subtype of lung adenocarcinoma in individuals, along with evaluating their response to immunotherapy.
Career Highlights
Faruki has worked with notable organizations such as GeneCentric Therapeutics, Inc. and the University of North Carolina at Chapel Hill. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Myla Lai-Goldman and Charles M Perou, who have also made significant contributions to cancer research.
Conclusion
Hawazin Faruki's innovative work in cancer research, particularly in the subtyping of bladder cancer and lung adenocarcinoma, showcases his commitment to advancing medical science. His patents reflect a dedication to improving therapeutic responses for patients, marking him as a key figure in the field.